Molbio Diagnostics IPO \u2013 Flattrade Kosh<\/title>\n <style>\n \/* --- PREMIUM UNIFIED EDITORIAL SYSTEM (CMR DESIGN STYLE) --- *\/\n *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }\n\n .cmr-article-wrapper {\n font-family: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, sans-serif;\n color: #2c3e50;\n max-width: 740px;\n margin: 0 auto;\n line-height: 1.8;\n padding: 32px px 60px;\n }\n\n \/* --- META BAR --- *\/\n .meta-bar {\n display: flex;\n align-items: center;\n gap: 12px;\n font-size: 13px;\n color: #64748b;\n margin-bottom: 16px;\n }\n \n .tag {\n background: #f4faf2;\n color: #339701;\n border: 1px solid rgba(51, 151, 1, 0.2);\n border-radius: 4px;\n padding: 2px 9px;\n font-weight: 600;\n font-size: 12px;\n text-transform: uppercase;\n letter-spacing: .5px;\n }\n\n h1.post-title {\n font-size: 24px;\n font-weight: 800;\n color: #1a252f;\n margin-bottom: 24px;\n line-height: 1.25;\n }\n\n h2.section-heading, .cmr-article-wrapper h2 {\n font-size: 18px;\n font-weight: 700;\n color: #1a252f;\n margin: 32px 0 16px 0;\n line-height: 1.3;\n }\n\n .cmr-article-wrapper p {\n font-size: 16px;\n margin-bottom: 20px;\n color: #34495e;\n text-align: justify;\n }\n\n .cmr-article-wrapper strong {\n color: #111111;\n font-weight: 600;\n }\n\n \/* --- SECTION TITLE SEPARATOR --- *\/\n .cmr-glance-title {\n font-size: 15px;\n font-weight: 700;\n color: #1a252f;\n margin: 20px 0 16px 0;\n text-transform: uppercase;\n letter-spacing: 0.5px;\n display: flex;\n align-items: center;\n gap: 10px;\n }\n\n .cmr-glance-title::after {\n content: '';\n flex: 1;\n height: 1px;\n background: #e2e8f0;\n }\n\n \/* --- IPO GLANCE GRID --- *\/\n .cmr-glance-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));\n gap: 12px;\n margin-bottom: 16px;\n }\n\n .cmr-glance-item {\n background: #ffffff;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n padding: 16px;\n box-shadow: 0 1px 3px rgba(0, 0, 0, 0.02);\n transition: all 0.2s ease;\n }\n\n .cmr-glance-item:hover {\n border-color: #cbd5e1;\n box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);\n }\n\n .cmr-glance-item.cmr-highlight {\n background: #f4faf2;\n border-color: rgba(51, 151, 1, 0.2);\n }\n\n .cmr-glance-item.cmr-highlight .cmr-g-value {\n color: #339701;\n }\n\n .cmr-g-label {\n font-size: 11px;\n color: #64748b;\n text-transform: uppercase;\n letter-spacing: 0.5px;\n margin-bottom: 6px;\n font-weight: 600;\n }\n\n .cmr-g-value {\n font-size: 16px;\n font-weight: 700;\n color: #1e293b;\n line-height: 1.2;\n }\n\n .cmr-g-sub {\n font-size: 12px;\n color: #64748b;\n margin-top: 4px;\n line-height: 1.3;\n }\n\n .glance-badge {\n display: block;\n background: #f8fafc;\n border: 1px solid #e2e8f0;\n border-radius: 6px;\n padding: 10px 14px;\n font-size: 13px;\n color: #475569;\n margin-bottom: 30px;\n font-weight: 500;\n }\n\n \/* --- MINIMAL HIGHLIGHT LIST --- *\/\n .cmr-feature-list {\n margin: 24px 0;\n padding-left: 0;\n list-style: none;\n }\n\n .cmr-feature-list li {\n position: relative;\n padding-left: 0;\n margin-bottom: 16px;\n font-size: 15.5px;\n color: #34495e;\n text-align: justify;\n }\n\n .cmr-feature-list li::before {\n content: none;\n }\n\n \/* --- MOBILE-OPTIMIZED TABLES --- *\/\n .table-container {\n width: 100%;\n overflow-x: auto;\n -webkit-overflow-scrolling: touch;\n margin: 20px 0;\n }\n\n .fin-table, .res-table {\n width: 100%;\n border-collapse: collapse;\n font-size: 15px;\n background: #ffffff;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n overflow: hidden;\n }\n\n .fin-table th, .fin-table td,\n .res-table th, .res-table td {\n padding: 12px 16px;\n border-bottom: 1px solid #e2e8f0;\n }\n\n .fin-table thead tr, .res-table thead tr {\n background: #f8fafc;\n }\n\n .fin-table th {\n font-weight: 700;\n color: #1e293b;\n text-align: right;\n }\n\n .fin-table th:first-child,\n .res-table th {\n text-align: left;\n }\n\n .fin-table td {\n color: #334155;\n text-align: right;\n }\n\n .res-table td {\n color: #334155;\n text-align: left;\n }\n\n .fin-table td:first-child,\n .res-table td:first-child {\n text-align: left;\n font-weight: 600;\n color: #1e293b;\n }\n\n .fin-table tbody tr:last-child td,\n .res-table tbody tr:last-child td {\n border-bottom: none;\n }\n\n .fin-note {\n font-size: 13px;\n color: #64748b;\n margin-top: -10px;\n margin-bottom: 24px;\n }\n\n \/* --- KPI GRID --- *\/\n .kpi-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(130px, 1fr));\n gap: 12px;\n margin: 24px 0;\n }\n\n .kpi-card {\n background: #ffffff;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n padding: 16px 12px;\n text-align: center;\n transition: all 0.2s ease;\n }\n\n .kpi-card:hover {\n border-color: #cbd5e1;\n }\n\n .kpi-card .kpi-value {\n font-size: 18px;\n font-weight: 700;\n color: #339701;\n line-height: 1.2;\n }\n\n .kpi-card .kpi-label {\n font-size: 11px;\n color: #64748b;\n text-transform: uppercase;\n letter-spacing: 0.5px;\n margin-top: 6px;\n font-weight: 600;\n }\n\n \/* --- OBJECTS MATRIX CONTAINER --- *\/\n .objects-list {\n list-style: none;\n padding: 0;\n margin: 20px 0;\n }\n\n .objects-list li {\n display: flex;\n justify-content: space-between;\n align-items: center;\n padding: 14px 18px;\n border-radius: 8px;\n margin-bottom: 10px;\n background: #f8fafc;\n border: 1px solid #e2e8f0;\n font-size: 15px;\n text-align: justify;\n }\n\n .objects-list li .obj-label {\n color: #334155;\n }\n\n .objects-list li .obj-amt {\n font-weight: 700;\n color: #1e293b;\n white-space: nowrap;\n margin-left: 12px;\n }\n\n \/* --- TAKEAWAY VERDICT CARD --- *\/\n .cmr-verdict-card {\n background: #f4faf2;\n border-left: 4px solid #339701;\n padding: 24px;\n border-radius: 0 8px 8px 0;\n margin: 40px 0;\n }\n\n .cmr-verdict-title {\n font-size: 18px;\n font-weight: 700;\n color: #1a252f;\n margin-bottom: 8px;\n }\n\n \/* --- CALL TO ACTION BUTTON --- *\/\n .cta-wrap {\n text-align: center;\n margin: 36px 0 20px;\n }\n\n .cta-btn {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n background-color: #339701;\n color: #ffffff !important;\n font-size: 16px;\n font-weight: 600;\n text-decoration: none !important;\n padding: 14px 36px;\n border-radius: 8px;\n box-shadow: 0 4px 14px rgba(51, 151, 1, 0.2);\n transition: all 0.2s ease-in-out;\n border: none;\n cursor: pointer;\n letter-spacing: 0.5px;\n }\n\n .cta-btn:hover {\n background-color: #277501;\n transform: translateY(-2px);\n box-shadow: 0 6px 20px rgba(51, 151, 1, 0.3);\n }\n\n .source-note {\n font-size: 12px;\n color: #94a3b8;\n margin-top: 32px;\n border-top: 1px solid #f1f5f9;\n padding-top: 12px;\n text-align: center;\n }\n\n \/* --- CLEAN SEPARATORS --- *\/\n hr.divider {\n border: none;\n border-top: 1px solid #e2e8f0;\n margin: 32px 0;\n }\n\n \/* RESPONSIVE LAYOUT BREAKPOINTS *\/\n @media (max-width: 600px) {\n .cmr-glance-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n .kpi-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n\n \/* AUTOMATED INTERACTIVE BLOCK COMPRESSION FOR SMALL MOBILE PHONES *\/\n .fin-table, .fin-table thead, .fin-table tbody, .fin-table th, .fin-table td, .fin-table tr,\n .res-table, .res-table thead, .res-table tbody, .res-table th, .res-table td, .res-table tr {\n display: block;\n }\n \n .fin-table thead, .res-table thead {\n display: none;\n }\n \n .fin-table tr, .res-table tr {\n margin-bottom: 12px;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n padding: 8px 0;\n }\n \n .fin-table td, .res-table td {\n text-align: right !important;\n padding: 6px 16px;\n border-bottom: 1px solid #f1f5f9;\n display: flex;\n justify-content: space-between;\n }\n\n .fin-table td:last-child, .res-table td:last-child {\n border-bottom: none;\n }\n\n .fin-table td::before, .res-table td::before {\n content: attr(data-label);\n font-weight: 700;\n color: #64748b;\n text-align: left;\n }\n }\n <\/style>\n<\/head>\n<body>\n\n<div class=\"cmr-article-wrapper\">\n\n \n <div class=\"cmr-glance-title\">IPO at a Glance<\/div>\n \n <div class=\"cmr-glance-grid\">\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Price Band<\/div>\n <div class=\"cmr-g-value\">\u20b9768 to \u20b9807<\/div>\n <div class=\"cmr-g-sub\">Face Value \u20b91 \/ share<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Issue Opens<\/div>\n <div class=\"cmr-g-value\">Aug 10<\/div>\n <div class=\"cmr-g-sub\">Closes Aug 12, 2026<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lot Size<\/div>\n <div class=\"cmr-g-value\">18 Shares<\/div>\n <div class=\"cmr-g-sub\">Min Investment: \u20b914,526<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Total Size<\/div>\n <div class=\"cmr-g-value\">\u20b9940 Cr<\/div>\n <div class=\"cmr-g-sub\">Fresh + OFS<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Listing At<\/div>\n <div class=\"cmr-g-value\">BSE & NSE<\/div>\n <div class=\"cmr-g-sub\">Tentative: Aug 17, 2026<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lead Manager<\/div>\n <div class=\"cmr-g-value\" style=\"font-size: 14px; font-weight: 600; color: #006666;\">Kotak Mahindra Capital<\/div>\n <div class=\"cmr-g-sub\">Registrar: Kfin Technologies<\/div>\n <\/div>\n <\/div>\n\n \n <h2>About the Company: Global Point-of-Care Molecular Diagnostics Innovator<\/h2>\n <p>\n Incorporated in <strong>October 2000<\/strong>, Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnostics company engaged in the research, development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases. The company has developed its proprietary <strong>‘Truenat’<\/strong> platform, a portable, battery-operated PCR-based molecular diagnostics system designed for resource-limited settings, offering accurate test results within an hour.\n <\/p>\n <p>\n Molbio offers molecular testing solutions for over 30 diseases through 43 diagnostic assays, including tuberculosis (TB), COVID-19, HIV, Hepatitis B & C, and HPV. The company also provides radiology, digital pathology, and breast health screening solutions through its subsidiaries and strategic collaborations, while continuously expanding its diagnostics product pipeline through strong in-house R&D capabilities.\n <\/p>\n <p>\n The company operates six manufacturing facilities across India and serves customers in over 90 countries, including government health programs, diagnostic laboratories, hospitals, and international healthcare organizations. Backed by a strong portfolio of patents, global certifications, and strategic acquisitions, Molbio has established itself as a leading innovator in molecular diagnostics. As of March 31, 2026, the company employed 1,225 permanent professionals.\n <\/p>\n\n <ul class=\"cmr-feature-list\">\n <li>\n Proprietary Truenat platform with WHO-endorsed TB molecular diagnostic technology.\n <\/li>\n <li>\n Strong R&D capabilities supported by an extensive global patent portfolio.\n <\/li>\n <li>\n Scalable business model with recurring revenues from diagnostic test kits.\n <\/li>\n <li>\n Global presence across 90+ countries with strong government and institutional customer base.\n <\/li>\n <li>\n Strategic acquisitions and collaborations expanding healthcare diagnostics portfolio.\n <\/li>\n <li>\n Experienced management team with deep expertise in molecular diagnostics and healthcare innovation.\n <\/li>\n <\/ul>\n\n <p>\n The company’s promoters are <strong>Chandrasekhar Bhaskaran Nair, Exxora Trading LLP, Sangeetha Sriram, Shiva Sriram, Sowmya Sriram, and Sriram Natarajan<\/strong>.\n <\/p>\n\n <hr class=\"divider\" \/>\n\n \n <h2>Financial Trends & Performance<\/h2>\n <p>\n Molbio Diagnostics Ltd.’s revenue increased by 42% and profit after tax (PAT) rose by 18% between the financial year ending with March 31, 2026 and March 31, 2025.\n <\/p>\n\n <div class=\"table-container\">\n <table class=\"fin-table\">\n <thead>\n <tr>\n <th>Period Ended<\/th>\n <th>31 Mar 2026<\/th>\n <th>31 Mar 2025<\/th>\n <th>31 Mar 2024<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>Total Assets<\/td><td data-label=\"31 Mar 2026\">\u20b92,148.42 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b91,461.56 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b91,221.06 Cr<\/td><\/tr>\n <tr><td>Total Income<\/td><td data-label=\"31 Mar 2026\">\u20b91,455.17 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b91,027.94 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9840.66 Cr<\/td><\/tr>\n <tr><td>Profit After Tax (PAT)<\/td><td data-label=\"31 Mar 2026\">\u20b9164.14 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9138.58 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b983.54 Cr<\/td><\/tr>\n <tr><td>EBITDA<\/td><td data-label=\"31 Mar 2026\">\u20b9328.24 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9256.64 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9185.09 Cr<\/td><\/tr>\n <tr><td>Net Worth<\/td><td data-label=\"31 Mar 2026\">\u20b91,144.68 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9952.95 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9807.94 Cr<\/td><\/tr>\n <tr><td>Reserves and Surplus<\/td><td data-label=\"31 Mar 2026\">\u20b91,148.84 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9990.84 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9845.48 Cr<\/td><\/tr>\n <tr><td>Total Borrowings<\/td><td data-label=\"31 Mar 2026\">\u20b9412.64 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9123.16 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9174.58 Cr<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"fin-note\">All figures in \u20b9 Crore | Source: Chittorgarh \/ DRHP (Restated)<\/p>\n\n \n <h2>Key Performance Indicators & Valuation (FY2026)<\/h2>\n <div class=\"kpi-grid\">\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">15.59%<\/div>\n <div class=\"kpi-label\">ROE (FY26)<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">17.55%<\/div>\n <div class=\"kpi-label\">ROCE (FY26)<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">11.28%<\/div>\n <div class=\"kpi-label\">PAT Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">22.56%<\/div>\n <div class=\"kpi-label\">EBITDA Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">\u20b9101.51<\/div>\n <div class=\"kpi-label\">NAV per share<\/div>\n <\/div>\n \n <\/div>\n\n <hr class=\"divider\" \/>\n\n \n <h2>Competitive Strengths<\/h2>\n <ul class=\"cmr-feature-list\">\n <li>\n <strong>WHO-Endorsed Technology:<\/strong> Proprietary Truenat platform featuring WHO-backed point-of-care molecular diagnostic solutions for TB and other infectious diseases.\n <\/li>\n <li>\n <strong>Extensive Patent Footprint:<\/strong> Robust in-house research and development infrastructure supported by an expanding international patent portfolio.\n <\/li>\n <li>\n <strong>Razor & Blade Business Model:<\/strong> Highly scalable revenue model driven by recurring sales of disease-specific diagnostic test kits.\n <\/li>\n <li>\n <strong>Global Reach:<\/strong> Commercial presence across 90+ countries with established government partnerships and healthcare institutional ties.\n <\/li>\n <\/ul>\n\n <hr class=\"divider\" \/>\n\n \n <h2>Issue Reservation<\/h2>\n <div class=\"table-container\">\n <table class=\"res-table\">\n <thead>\n <tr>\n <th>Investor Category<\/th>\n <th>Shares Offered<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>QIB Shares Offered<\/td><td>Not more than 50% of the Net Offer<\/td><\/tr>\n <tr><td>Retail Shares Offered<\/td><td>Not less than 35% of the Net Offer<\/td><\/tr>\n <tr><td>NII Shares Offered<\/td><td>Not less than 15% of the Net Offer<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n\n <hr class=\"divider\" \/>\n\n \n <h2>IPO Structure & Use of Proceeds<\/h2>\n <p>\n The \u20b9939.70 Cr issue comprises a Fresh Issue of \u20b9200.00 Cr (24,80,246 shares) and an Offer for Sale of \u20b9739.70 Cr (91,66,000 shares) by selling shareholders. The net fresh proceeds are proposed to be utilized as follows:\n <\/p>\n\n <ul class=\"objects-list\">\n <li>\n <span class=\"obj-label\">Funding capital expenditure towards setting up infrastructure for R&D facility, Center of Excellence, and connected office space<\/span>\n <span class=\"obj-amt\">\u20b9125.12 Cr<\/span>\n <\/li>\n <li>\n <span class=\"obj-label\">Funding capital expenditure towards purchase of plant, machinery, and equipment for Goa Unit I, Goa Unit II, and Visakhapatnam Unit<\/span>\n <span class=\"obj-amt\">\u20b980.81 Cr<\/span>\n <\/li>\n <li>\n <span class=\"obj-label\">General Corporate Purposes<\/span>\n <span class=\"obj-amt\">Balance<\/span>\n <\/li>\n <\/ul>\n\n <p>\n Bidding opens on <strong>August 10, 2026<\/strong> and closes on <strong>August 12, 2026<\/strong>. Minimum retail application lot size is fixed at 18 shares (\u20b914,526 based on the upper price band).\n <\/p>\n\n \n <div class=\"cmr-verdict-card\">\n <div class=\"cmr-verdict-title\">The Final Verdict<\/div>\n <p>\n Molbio Diagnostics Limited stands as a premier medical technology company, pioneering point-of-care molecular testing with its globally recognized Truenat platform. The business model combines high-margin, recurring diagnostic kit sales with expanding international adoption.\n <\/p>\n <p style=\"margin-top: 12px;\">\n Financial growth remains strong, with total income surging 42% in FY26 to \u20b91,455.17 Cr and PAT reaching \u20b9164.14 Cr. Allocating fresh capital toward expanding R&D infrastructure, setting up a Center of Excellence, and boosting production capacity in Goa and Visakhapatnam will solidify its long-term market leadership. Investors interested in innovative healthcare technology and point-of-care diagnostics may track this offering closely.\n <\/p>\n <\/div>\n\n \n <div class=\"cta-wrap\">\n <a class=\"cta-btn\" href=\"https:\/\/novo.flattrade.in\/\" target=\"_blank\" rel=\"noopener\">\n Apply for Molbio Diagnostics IPO on Flattrade\n <\/a>\n <\/div>\n\n <div class=\"source-note\">Source: Chittorgarh IPO Filings<\/div>\n\n<\/div>\n\n<\/body>\n<\/html>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bd02505 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bd02505\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-82c2052\" data-id=\"82c2052\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a488634 elementor-widget elementor-widget-text-editor\" data-id=\"a488634\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/google.com\/preferences\/source?q=https:\/\/flattrade.in\/\" class=\"ft-google-mini-btn\">\n\n\n <div class=\"mini-btn-content\">\n\n <span class=\"mini-top\">\n Stay updated with\n <\/span>\n\n <span class=\"mini-main\">\n\n <span class=\"flattrade-logo\">\n FLAT<span>TRADE<\/span>\n <small>KOSH<\/small>\n <\/span>\n \n\n on\n\n <span class=\"google-text\">\n <span class=\"g-blue\">G<\/span><span class=\"g-red\">o<\/span><span class=\"g-yellow\">o<\/span><span class=\"g-blue\">g<\/span><span class=\"g-green\">l<\/span><span class=\"g-red\">e<\/span>\n <\/span>\n\n <span class=\"arrow\">\u2197<\/span>\n\n <\/span>\n\n <span class=\"mini-desc\">\n Get market insights, IPO updates, and finance explainers more easily.\n <\/span>\n\n <\/div>\n\n<\/a>\n\n<style>\n\n\/* =========================\n FONT\n========================= *\/\n\n\n\/* =========================\n GLOBAL\n========================= *\/\n\n*{\n box-sizing:border-box;\n}\n\n\/* =========================\n BUTTON\n========================= *\/\n\n.ft-google-mini-btn{\n\n position:relative;\n\n display:inline-flex;\n\n align-items:center;\n\n gap:14px;\n\n width:100%;\n max-width:420px;\n\n padding:14px 16px;\n\n border-radius:18px;\n\n text-decoration:none;\n\n overflow:hidden;\n\n font-family:'Plus Jakarta Sans',sans-serif;\n\n border:1px solid #e5ebf5;\n\n background:\n linear-gradient(\n 135deg,\n #ffffff 0%,\n #f8fbff 50%,\n #f4f8fd 100%\n );\n\n box-shadow:\n 0 3px 8px rgba(15,23,42,0.03),\n 0 10px 20px rgba(15,23,42,0.05);\n\n transition:\n transform 0.25s ease,\n box-shadow 0.25s ease;\n}\n\n\/* =========================\n HOVER\n========================= *\/\n\n.ft-google-mini-btn:hover{\n\n transform:translateY(-2px);\n\n box-shadow:\n 0 8px 18px rgba(15,23,42,0.06),\n 0 18px 30px rgba(37,99,235,0.07);\n}\n\n\/* =========================\n GOOGLE ICON\n========================= *\/\n\n.google-icon{\n\n width:42px;\n\n height:42px;\n\n min-width:42px;\n}\n\n\/* =========================\n CONTENT\n========================= *\/\n\n.mini-btn-content{\n display:flex;\n flex-direction:column;\n}\n\n\/* =========================\n TOP TEXT\n========================= *\/\n\n.mini-top{\n\n font-size:11px;\n\n line-height:1.3;\n\n font-weight:700;\n\n color:#64748b;\n\n margin-bottom:2px;\n}\n\n\/* =========================\n MAIN TEXT\n========================= *\/\n\n.mini-main{\n\n font-size:15px;\n\n line-height:1.35;\n\n font-weight:800;\n\n color:#0f172a;\n}\n\n\/* =========================\n FLATTRADE LOGO\n========================= *\/\n\n.flattrade-logo{\n\n position:relative;\n\n display:inline-block;\n\n font-size:15px;\n\n font-weight:800;\n\n letter-spacing:-0.3px;\n\n color:#111827;\n}\n\n.flattrade-logo span{\n color:#2563eb;\n}\n\n.flattrade-logo small{\n\n position:absolute;\n\n right:-1px;\n\n bottom:-5px;\n\n font-size:4px;\n\n font-weight:800;\n\n color:#2563eb;\n\n letter-spacing:0.4px;\n}\n\n\/* =========================\n GOOGLE COLORS\n========================= *\/\n\n.google-text{\n font-weight:800;\n}\n\n.g-blue{\n color:#4285F4;\n}\n\n.g-red{\n color:#EA4335;\n}\n\n.g-yellow{\n color:#FBBC05;\n}\n\n.g-green{\n color:#34A853;\n}\n\n\/* =========================\n ARROW\n========================= *\/\n\n.arrow{\n color:#2563eb;\n}\n\n\/* =========================\n DESCRIPTION\n========================= *\/\n\n.mini-desc{\n\n margin-top:4px;\n\n font-size:10px;\n\n line-height:1.5;\n\n font-weight:500;\n\n color:#64748b;\n}\n\n\/* =========================\n MOBILE\n========================= *\/\n\n@media(max-width:480px){\n\n .ft-google-mini-btn{\n\n max-width:100%;\n\n padding:12px 14px;\n\n border-radius:16px;\n }\n\n .google-icon{\n\n width:36px;\n\n height:36px;\n\n min-width:36px;\n }\n\n .mini-main,\n .flattrade-logo{\n font-size:13px;\n }\n\n .mini-desc{\n font-size:9px;\n }\n\n}\n\n.ft-google-mini-btn {\n position: relative;\n display: inline-flex;\n align-items: center;\n gap: 14px;\n width: 100%;\n max-width: 420px;\n padding: 14px 16px;\n border-radius: 18px;\n text-decoration: none;\n overflow: hidden;\n font-family: 'Plus Jakarta Sans', sans-serif;\n\n \/* --- ENHANCED BORDER --- *\/\n border: 2px solid #2563eb; \/* Using the brand blue for a strong identity *\/\n \/* Alternative: border: 1.5px solid #cbd5e1; for a subtle slate grey *\/\n \n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 50%, #f4f8fd 100%);\n box-shadow: 0 3px 8px rgba(15,23,42,0.03), 0 10px 20px rgba(15,23,42,0.05);\n transition: all 0.25s ease;\n}\n\n\/* =========================\n HOVER STATE BORDER\n========================= *\/\n.ft-google-mini-btn:hover {\n transform: translateY(-2px);\n border-color: #c5d4ff; \/* Darkens the border slightly on hover *\/\n box-shadow: 0 8px 12px rgba(37,99,235,0.15);\n}\n\n\n\n<\/style>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Molbio Diagnostics IPO \u2013 Flattrade Kosh IPO at a Glance Price Band \u20b9768 to \u20b9807 Face Value \u20b91…","protected":false},"author":10,"featured_media":52774,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"csco_post_video_bg_volume":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-52769","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ipos","cs-entry","cs-video-wrap"],"yoast_head":"\n<title>Molbio Diagnostics IPO - Flattrade Kosh<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molbio Diagnostics IPO - Flattrade Kosh\" \/>\n<meta property=\"og:description\" content=\"Molbio Diagnostics IPO \u2013 Flattrade Kosh IPO at a Glance Price Band \u20b9768 to \u20b9807 Face Value \u20b91…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"Flattrade Kosh\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-07T12:55:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1480\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Prashant Gorhe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@GorhePrashant\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prashant Gorhe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\"},\"author\":{\"name\":\"Prashant Gorhe\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"headline\":\"Molbio Diagnostics IPO\",\"datePublished\":\"2026-08-07T12:55:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\"},\"wordCount\":733,\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"articleSection\":[\"IPOs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\",\"url\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\",\"name\":\"Molbio Diagnostics IPO - Flattrade Kosh\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"datePublished\":\"2026-08-07T12:55:00+00:00\",\"author\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"breadcrumb\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\",\"url\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"contentUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"width\":1480,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/flattrade.in\/kosh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molbio Diagnostics IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\",\"url\":\"https:\/\/flattrade.in\/kosh\/\",\"name\":\"Flattrade Kosh\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/flattrade.in\/kosh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\",\"name\":\"Prashant Gorhe\",\"sameAs\":[\"http:\/\/prashantgorhe.com\",\"https:\/\/www.instagram.com\/prashant_gorhe\/\",\"https:\/\/www.linkedin.com\/in\/prashantgorhe\/\",\"https:\/\/x.com\/GorhePrashant\"],\"url\":\"https:\/\/flattrade.in\/kosh\/author\/prashant\/\"}]}<\/script>\n","yoast_head_json":{"title":"Molbio Diagnostics IPO - Flattrade Kosh","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Molbio Diagnostics IPO - Flattrade Kosh","og_description":"Molbio Diagnostics IPO \u2013 Flattrade Kosh IPO at a Glance Price Band \u20b9768 to \u20b9807 Face Value \u20b91…","og_url":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","og_site_name":"Flattrade Kosh","article_published_time":"2026-08-07T12:55:00+00:00","og_image":[{"width":1480,"height":1000,"url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","type":"image\/jpeg"}],"author":"Prashant Gorhe","twitter_card":"summary_large_image","twitter_creator":"@GorhePrashant","twitter_misc":{"Written by":"Prashant Gorhe","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#article","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/"},"author":{"name":"Prashant Gorhe","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"headline":"Molbio Diagnostics IPO","datePublished":"2026-08-07T12:55:00+00:00","mainEntityOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/"},"wordCount":733,"image":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","articleSection":["IPOs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","url":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","name":"Molbio Diagnostics IPO - Flattrade Kosh","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage"},"image":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","datePublished":"2026-08-07T12:55:00+00:00","author":{"@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"breadcrumb":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage","url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","contentUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","width":1480,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flattrade.in\/kosh\/"},{"@type":"ListItem","position":2,"name":"Molbio Diagnostics IPO"}]},{"@type":"WebSite","@id":"https:\/\/flattrade.in\/kosh\/#website","url":"https:\/\/flattrade.in\/kosh\/","name":"Flattrade Kosh","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flattrade.in\/kosh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2","name":"Prashant Gorhe","sameAs":["http:\/\/prashantgorhe.com","https:\/\/www.instagram.com\/prashant_gorhe\/","https:\/\/www.linkedin.com\/in\/prashantgorhe\/","https:\/\/x.com\/GorhePrashant"],"url":"https:\/\/flattrade.in\/kosh\/author\/prashant\/"}]}},"_links":{"self":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/comments?post=52769"}],"version-history":[{"count":0,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52769\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media\/52774"}],"wp:attachment":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media?parent=52769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/categories?post=52769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/tags?post=52769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\n\t\t\t\t\t\t

\n\t\t\t\t\t

\n\t\t\t

\n\t\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\n\n\n \n \n Molbio Diagnostics IPO \u2013 Flattrade Kosh<\/title>\n <style>\n \/* --- PREMIUM UNIFIED EDITORIAL SYSTEM (CMR DESIGN STYLE) --- *\/\n *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }\n\n .cmr-article-wrapper {\n font-family: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, sans-serif;\n color: #2c3e50;\n max-width: 740px;\n margin: 0 auto;\n line-height: 1.8;\n padding: 32px px 60px;\n }\n\n \/* --- META BAR --- *\/\n .meta-bar {\n display: flex;\n align-items: center;\n gap: 12px;\n font-size: 13px;\n color: #64748b;\n margin-bottom: 16px;\n }\n \n .tag {\n background: #f4faf2;\n color: #339701;\n border: 1px solid rgba(51, 151, 1, 0.2);\n border-radius: 4px;\n padding: 2px 9px;\n font-weight: 600;\n font-size: 12px;\n text-transform: uppercase;\n letter-spacing: .5px;\n }\n\n h1.post-title {\n font-size: 24px;\n font-weight: 800;\n color: #1a252f;\n margin-bottom: 24px;\n line-height: 1.25;\n }\n\n h2.section-heading, .cmr-article-wrapper h2 {\n font-size: 18px;\n font-weight: 700;\n color: #1a252f;\n margin: 32px 0 16px 0;\n line-height: 1.3;\n }\n\n .cmr-article-wrapper p {\n font-size: 16px;\n margin-bottom: 20px;\n color: #34495e;\n text-align: justify;\n }\n\n .cmr-article-wrapper strong {\n color: #111111;\n font-weight: 600;\n }\n\n \/* --- SECTION TITLE SEPARATOR --- *\/\n .cmr-glance-title {\n font-size: 15px;\n font-weight: 700;\n color: #1a252f;\n margin: 20px 0 16px 0;\n text-transform: uppercase;\n letter-spacing: 0.5px;\n display: flex;\n align-items: center;\n gap: 10px;\n }\n\n .cmr-glance-title::after {\n content: '';\n flex: 1;\n height: 1px;\n background: #e2e8f0;\n }\n\n \/* --- IPO GLANCE GRID --- *\/\n .cmr-glance-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(160px, 1fr));\n gap: 12px;\n margin-bottom: 16px;\n }\n\n .cmr-glance-item {\n background: #ffffff;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n padding: 16px;\n box-shadow: 0 1px 3px rgba(0, 0, 0, 0.02);\n transition: all 0.2s ease;\n }\n\n .cmr-glance-item:hover {\n border-color: #cbd5e1;\n box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);\n }\n\n .cmr-glance-item.cmr-highlight {\n background: #f4faf2;\n border-color: rgba(51, 151, 1, 0.2);\n }\n\n .cmr-glance-item.cmr-highlight .cmr-g-value {\n color: #339701;\n }\n\n .cmr-g-label {\n font-size: 11px;\n color: #64748b;\n text-transform: uppercase;\n letter-spacing: 0.5px;\n margin-bottom: 6px;\n font-weight: 600;\n }\n\n .cmr-g-value {\n font-size: 16px;\n font-weight: 700;\n color: #1e293b;\n line-height: 1.2;\n }\n\n .cmr-g-sub {\n font-size: 12px;\n color: #64748b;\n margin-top: 4px;\n line-height: 1.3;\n }\n\n .glance-badge {\n display: block;\n background: #f8fafc;\n border: 1px solid #e2e8f0;\n border-radius: 6px;\n padding: 10px 14px;\n font-size: 13px;\n color: #475569;\n margin-bottom: 30px;\n font-weight: 500;\n }\n\n \/* --- MINIMAL HIGHLIGHT LIST --- *\/\n .cmr-feature-list {\n margin: 24px 0;\n padding-left: 0;\n list-style: none;\n }\n\n .cmr-feature-list li {\n position: relative;\n padding-left: 0;\n margin-bottom: 16px;\n font-size: 15.5px;\n color: #34495e;\n text-align: justify;\n }\n\n .cmr-feature-list li::before {\n content: none;\n }\n\n \/* --- MOBILE-OPTIMIZED TABLES --- *\/\n .table-container {\n width: 100%;\n overflow-x: auto;\n -webkit-overflow-scrolling: touch;\n margin: 20px 0;\n }\n\n .fin-table, .res-table {\n width: 100%;\n border-collapse: collapse;\n font-size: 15px;\n background: #ffffff;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n overflow: hidden;\n }\n\n .fin-table th, .fin-table td,\n .res-table th, .res-table td {\n padding: 12px 16px;\n border-bottom: 1px solid #e2e8f0;\n }\n\n .fin-table thead tr, .res-table thead tr {\n background: #f8fafc;\n }\n\n .fin-table th {\n font-weight: 700;\n color: #1e293b;\n text-align: right;\n }\n\n .fin-table th:first-child,\n .res-table th {\n text-align: left;\n }\n\n .fin-table td {\n color: #334155;\n text-align: right;\n }\n\n .res-table td {\n color: #334155;\n text-align: left;\n }\n\n .fin-table td:first-child,\n .res-table td:first-child {\n text-align: left;\n font-weight: 600;\n color: #1e293b;\n }\n\n .fin-table tbody tr:last-child td,\n .res-table tbody tr:last-child td {\n border-bottom: none;\n }\n\n .fin-note {\n font-size: 13px;\n color: #64748b;\n margin-top: -10px;\n margin-bottom: 24px;\n }\n\n \/* --- KPI GRID --- *\/\n .kpi-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(130px, 1fr));\n gap: 12px;\n margin: 24px 0;\n }\n\n .kpi-card {\n background: #ffffff;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n padding: 16px 12px;\n text-align: center;\n transition: all 0.2s ease;\n }\n\n .kpi-card:hover {\n border-color: #cbd5e1;\n }\n\n .kpi-card .kpi-value {\n font-size: 18px;\n font-weight: 700;\n color: #339701;\n line-height: 1.2;\n }\n\n .kpi-card .kpi-label {\n font-size: 11px;\n color: #64748b;\n text-transform: uppercase;\n letter-spacing: 0.5px;\n margin-top: 6px;\n font-weight: 600;\n }\n\n \/* --- OBJECTS MATRIX CONTAINER --- *\/\n .objects-list {\n list-style: none;\n padding: 0;\n margin: 20px 0;\n }\n\n .objects-list li {\n display: flex;\n justify-content: space-between;\n align-items: center;\n padding: 14px 18px;\n border-radius: 8px;\n margin-bottom: 10px;\n background: #f8fafc;\n border: 1px solid #e2e8f0;\n font-size: 15px;\n text-align: justify;\n }\n\n .objects-list li .obj-label {\n color: #334155;\n }\n\n .objects-list li .obj-amt {\n font-weight: 700;\n color: #1e293b;\n white-space: nowrap;\n margin-left: 12px;\n }\n\n \/* --- TAKEAWAY VERDICT CARD --- *\/\n .cmr-verdict-card {\n background: #f4faf2;\n border-left: 4px solid #339701;\n padding: 24px;\n border-radius: 0 8px 8px 0;\n margin: 40px 0;\n }\n\n .cmr-verdict-title {\n font-size: 18px;\n font-weight: 700;\n color: #1a252f;\n margin-bottom: 8px;\n }\n\n \/* --- CALL TO ACTION BUTTON --- *\/\n .cta-wrap {\n text-align: center;\n margin: 36px 0 20px;\n }\n\n .cta-btn {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n background-color: #339701;\n color: #ffffff !important;\n font-size: 16px;\n font-weight: 600;\n text-decoration: none !important;\n padding: 14px 36px;\n border-radius: 8px;\n box-shadow: 0 4px 14px rgba(51, 151, 1, 0.2);\n transition: all 0.2s ease-in-out;\n border: none;\n cursor: pointer;\n letter-spacing: 0.5px;\n }\n\n .cta-btn:hover {\n background-color: #277501;\n transform: translateY(-2px);\n box-shadow: 0 6px 20px rgba(51, 151, 1, 0.3);\n }\n\n .source-note {\n font-size: 12px;\n color: #94a3b8;\n margin-top: 32px;\n border-top: 1px solid #f1f5f9;\n padding-top: 12px;\n text-align: center;\n }\n\n \/* --- CLEAN SEPARATORS --- *\/\n hr.divider {\n border: none;\n border-top: 1px solid #e2e8f0;\n margin: 32px 0;\n }\n\n \/* RESPONSIVE LAYOUT BREAKPOINTS *\/\n @media (max-width: 600px) {\n .cmr-glance-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n .kpi-grid {\n grid-template-columns: repeat(2, 1fr);\n }\n\n \/* AUTOMATED INTERACTIVE BLOCK COMPRESSION FOR SMALL MOBILE PHONES *\/\n .fin-table, .fin-table thead, .fin-table tbody, .fin-table th, .fin-table td, .fin-table tr,\n .res-table, .res-table thead, .res-table tbody, .res-table th, .res-table td, .res-table tr {\n display: block;\n }\n \n .fin-table thead, .res-table thead {\n display: none;\n }\n \n .fin-table tr, .res-table tr {\n margin-bottom: 12px;\n border: 1px solid #e2e8f0;\n border-radius: 8px;\n padding: 8px 0;\n }\n \n .fin-table td, .res-table td {\n text-align: right !important;\n padding: 6px 16px;\n border-bottom: 1px solid #f1f5f9;\n display: flex;\n justify-content: space-between;\n }\n\n .fin-table td:last-child, .res-table td:last-child {\n border-bottom: none;\n }\n\n .fin-table td::before, .res-table td::before {\n content: attr(data-label);\n font-weight: 700;\n color: #64748b;\n text-align: left;\n }\n }\n <\/style>\n<\/head>\n<body>\n\n<div class=\"cmr-article-wrapper\">\n\n \n <div class=\"cmr-glance-title\">IPO at a Glance<\/div>\n \n <div class=\"cmr-glance-grid\">\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Price Band<\/div>\n <div class=\"cmr-g-value\">\u20b9768 to \u20b9807<\/div>\n <div class=\"cmr-g-sub\">Face Value \u20b91 \/ share<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item cmr-highlight\">\n <div class=\"cmr-g-label\">Issue Opens<\/div>\n <div class=\"cmr-g-value\">Aug 10<\/div>\n <div class=\"cmr-g-sub\">Closes Aug 12, 2026<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lot Size<\/div>\n <div class=\"cmr-g-value\">18 Shares<\/div>\n <div class=\"cmr-g-sub\">Min Investment: \u20b914,526<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Total Size<\/div>\n <div class=\"cmr-g-value\">\u20b9940 Cr<\/div>\n <div class=\"cmr-g-sub\">Fresh + OFS<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Listing At<\/div>\n <div class=\"cmr-g-value\">BSE & NSE<\/div>\n <div class=\"cmr-g-sub\">Tentative: Aug 17, 2026<\/div>\n <\/div>\n\n <div class=\"cmr-glance-item\">\n <div class=\"cmr-g-label\">Lead Manager<\/div>\n <div class=\"cmr-g-value\" style=\"font-size: 14px; font-weight: 600; color: #006666;\">Kotak Mahindra Capital<\/div>\n <div class=\"cmr-g-sub\">Registrar: Kfin Technologies<\/div>\n <\/div>\n <\/div>\n\n \n <h2>About the Company: Global Point-of-Care Molecular Diagnostics Innovator<\/h2>\n <p>\n Incorporated in <strong>October 2000<\/strong>, Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnostics company engaged in the research, development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases. The company has developed its proprietary <strong>‘Truenat’<\/strong> platform, a portable, battery-operated PCR-based molecular diagnostics system designed for resource-limited settings, offering accurate test results within an hour.\n <\/p>\n <p>\n Molbio offers molecular testing solutions for over 30 diseases through 43 diagnostic assays, including tuberculosis (TB), COVID-19, HIV, Hepatitis B & C, and HPV. The company also provides radiology, digital pathology, and breast health screening solutions through its subsidiaries and strategic collaborations, while continuously expanding its diagnostics product pipeline through strong in-house R&D capabilities.\n <\/p>\n <p>\n The company operates six manufacturing facilities across India and serves customers in over 90 countries, including government health programs, diagnostic laboratories, hospitals, and international healthcare organizations. Backed by a strong portfolio of patents, global certifications, and strategic acquisitions, Molbio has established itself as a leading innovator in molecular diagnostics. As of March 31, 2026, the company employed 1,225 permanent professionals.\n <\/p>\n\n <ul class=\"cmr-feature-list\">\n <li>\n Proprietary Truenat platform with WHO-endorsed TB molecular diagnostic technology.\n <\/li>\n <li>\n Strong R&D capabilities supported by an extensive global patent portfolio.\n <\/li>\n <li>\n Scalable business model with recurring revenues from diagnostic test kits.\n <\/li>\n <li>\n Global presence across 90+ countries with strong government and institutional customer base.\n <\/li>\n <li>\n Strategic acquisitions and collaborations expanding healthcare diagnostics portfolio.\n <\/li>\n <li>\n Experienced management team with deep expertise in molecular diagnostics and healthcare innovation.\n <\/li>\n <\/ul>\n\n <p>\n The company’s promoters are <strong>Chandrasekhar Bhaskaran Nair, Exxora Trading LLP, Sangeetha Sriram, Shiva Sriram, Sowmya Sriram, and Sriram Natarajan<\/strong>.\n <\/p>\n\n <hr class=\"divider\" \/>\n\n \n <h2>Financial Trends & Performance<\/h2>\n <p>\n Molbio Diagnostics Ltd.’s revenue increased by 42% and profit after tax (PAT) rose by 18% between the financial year ending with March 31, 2026 and March 31, 2025.\n <\/p>\n\n <div class=\"table-container\">\n <table class=\"fin-table\">\n <thead>\n <tr>\n <th>Period Ended<\/th>\n <th>31 Mar 2026<\/th>\n <th>31 Mar 2025<\/th>\n <th>31 Mar 2024<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>Total Assets<\/td><td data-label=\"31 Mar 2026\">\u20b92,148.42 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b91,461.56 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b91,221.06 Cr<\/td><\/tr>\n <tr><td>Total Income<\/td><td data-label=\"31 Mar 2026\">\u20b91,455.17 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b91,027.94 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9840.66 Cr<\/td><\/tr>\n <tr><td>Profit After Tax (PAT)<\/td><td data-label=\"31 Mar 2026\">\u20b9164.14 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9138.58 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b983.54 Cr<\/td><\/tr>\n <tr><td>EBITDA<\/td><td data-label=\"31 Mar 2026\">\u20b9328.24 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9256.64 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9185.09 Cr<\/td><\/tr>\n <tr><td>Net Worth<\/td><td data-label=\"31 Mar 2026\">\u20b91,144.68 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9952.95 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9807.94 Cr<\/td><\/tr>\n <tr><td>Reserves and Surplus<\/td><td data-label=\"31 Mar 2026\">\u20b91,148.84 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9990.84 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9845.48 Cr<\/td><\/tr>\n <tr><td>Total Borrowings<\/td><td data-label=\"31 Mar 2026\">\u20b9412.64 Cr<\/td><td data-label=\"31 Mar 2025\">\u20b9123.16 Cr<\/td><td data-label=\"31 Mar 2024\">\u20b9174.58 Cr<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n <p class=\"fin-note\">All figures in \u20b9 Crore | Source: Chittorgarh \/ DRHP (Restated)<\/p>\n\n \n <h2>Key Performance Indicators & Valuation (FY2026)<\/h2>\n <div class=\"kpi-grid\">\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">15.59%<\/div>\n <div class=\"kpi-label\">ROE (FY26)<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">17.55%<\/div>\n <div class=\"kpi-label\">ROCE (FY26)<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">11.28%<\/div>\n <div class=\"kpi-label\">PAT Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">22.56%<\/div>\n <div class=\"kpi-label\">EBITDA Margin<\/div>\n <\/div>\n <div class=\"kpi-card\">\n <div class=\"kpi-value\">\u20b9101.51<\/div>\n <div class=\"kpi-label\">NAV per share<\/div>\n <\/div>\n \n <\/div>\n\n <hr class=\"divider\" \/>\n\n \n <h2>Competitive Strengths<\/h2>\n <ul class=\"cmr-feature-list\">\n <li>\n <strong>WHO-Endorsed Technology:<\/strong> Proprietary Truenat platform featuring WHO-backed point-of-care molecular diagnostic solutions for TB and other infectious diseases.\n <\/li>\n <li>\n <strong>Extensive Patent Footprint:<\/strong> Robust in-house research and development infrastructure supported by an expanding international patent portfolio.\n <\/li>\n <li>\n <strong>Razor & Blade Business Model:<\/strong> Highly scalable revenue model driven by recurring sales of disease-specific diagnostic test kits.\n <\/li>\n <li>\n <strong>Global Reach:<\/strong> Commercial presence across 90+ countries with established government partnerships and healthcare institutional ties.\n <\/li>\n <\/ul>\n\n <hr class=\"divider\" \/>\n\n \n <h2>Issue Reservation<\/h2>\n <div class=\"table-container\">\n <table class=\"res-table\">\n <thead>\n <tr>\n <th>Investor Category<\/th>\n <th>Shares Offered<\/th>\n <\/tr>\n <\/thead>\n <tbody>\n <tr><td>QIB Shares Offered<\/td><td>Not more than 50% of the Net Offer<\/td><\/tr>\n <tr><td>Retail Shares Offered<\/td><td>Not less than 35% of the Net Offer<\/td><\/tr>\n <tr><td>NII Shares Offered<\/td><td>Not less than 15% of the Net Offer<\/td><\/tr>\n <\/tbody>\n <\/table>\n <\/div>\n\n <hr class=\"divider\" \/>\n\n \n <h2>IPO Structure & Use of Proceeds<\/h2>\n <p>\n The \u20b9939.70 Cr issue comprises a Fresh Issue of \u20b9200.00 Cr (24,80,246 shares) and an Offer for Sale of \u20b9739.70 Cr (91,66,000 shares) by selling shareholders. The net fresh proceeds are proposed to be utilized as follows:\n <\/p>\n\n <ul class=\"objects-list\">\n <li>\n <span class=\"obj-label\">Funding capital expenditure towards setting up infrastructure for R&D facility, Center of Excellence, and connected office space<\/span>\n <span class=\"obj-amt\">\u20b9125.12 Cr<\/span>\n <\/li>\n <li>\n <span class=\"obj-label\">Funding capital expenditure towards purchase of plant, machinery, and equipment for Goa Unit I, Goa Unit II, and Visakhapatnam Unit<\/span>\n <span class=\"obj-amt\">\u20b980.81 Cr<\/span>\n <\/li>\n <li>\n <span class=\"obj-label\">General Corporate Purposes<\/span>\n <span class=\"obj-amt\">Balance<\/span>\n <\/li>\n <\/ul>\n\n <p>\n Bidding opens on <strong>August 10, 2026<\/strong> and closes on <strong>August 12, 2026<\/strong>. Minimum retail application lot size is fixed at 18 shares (\u20b914,526 based on the upper price band).\n <\/p>\n\n \n <div class=\"cmr-verdict-card\">\n <div class=\"cmr-verdict-title\">The Final Verdict<\/div>\n <p>\n Molbio Diagnostics Limited stands as a premier medical technology company, pioneering point-of-care molecular testing with its globally recognized Truenat platform. The business model combines high-margin, recurring diagnostic kit sales with expanding international adoption.\n <\/p>\n <p style=\"margin-top: 12px;\">\n Financial growth remains strong, with total income surging 42% in FY26 to \u20b91,455.17 Cr and PAT reaching \u20b9164.14 Cr. Allocating fresh capital toward expanding R&D infrastructure, setting up a Center of Excellence, and boosting production capacity in Goa and Visakhapatnam will solidify its long-term market leadership. Investors interested in innovative healthcare technology and point-of-care diagnostics may track this offering closely.\n <\/p>\n <\/div>\n\n \n <div class=\"cta-wrap\">\n <a class=\"cta-btn\" href=\"https:\/\/novo.flattrade.in\/\" target=\"_blank\" rel=\"noopener\">\n Apply for Molbio Diagnostics IPO on Flattrade\n <\/a>\n <\/div>\n\n <div class=\"source-note\">Source: Chittorgarh IPO Filings<\/div>\n\n<\/div>\n\n<\/body>\n<\/html>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bd02505 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bd02505\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-82c2052\" data-id=\"82c2052\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a488634 elementor-widget elementor-widget-text-editor\" data-id=\"a488634\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/google.com\/preferences\/source?q=https:\/\/flattrade.in\/\" class=\"ft-google-mini-btn\">\n\n\n <div class=\"mini-btn-content\">\n\n <span class=\"mini-top\">\n Stay updated with\n <\/span>\n\n <span class=\"mini-main\">\n\n <span class=\"flattrade-logo\">\n FLAT<span>TRADE<\/span>\n <small>KOSH<\/small>\n <\/span>\n \n\n on\n\n <span class=\"google-text\">\n <span class=\"g-blue\">G<\/span><span class=\"g-red\">o<\/span><span class=\"g-yellow\">o<\/span><span class=\"g-blue\">g<\/span><span class=\"g-green\">l<\/span><span class=\"g-red\">e<\/span>\n <\/span>\n\n <span class=\"arrow\">\u2197<\/span>\n\n <\/span>\n\n <span class=\"mini-desc\">\n Get market insights, IPO updates, and finance explainers more easily.\n <\/span>\n\n <\/div>\n\n<\/a>\n\n<style>\n\n\/* =========================\n FONT\n========================= *\/\n\n\n\/* =========================\n GLOBAL\n========================= *\/\n\n*{\n box-sizing:border-box;\n}\n\n\/* =========================\n BUTTON\n========================= *\/\n\n.ft-google-mini-btn{\n\n position:relative;\n\n display:inline-flex;\n\n align-items:center;\n\n gap:14px;\n\n width:100%;\n max-width:420px;\n\n padding:14px 16px;\n\n border-radius:18px;\n\n text-decoration:none;\n\n overflow:hidden;\n\n font-family:'Plus Jakarta Sans',sans-serif;\n\n border:1px solid #e5ebf5;\n\n background:\n linear-gradient(\n 135deg,\n #ffffff 0%,\n #f8fbff 50%,\n #f4f8fd 100%\n );\n\n box-shadow:\n 0 3px 8px rgba(15,23,42,0.03),\n 0 10px 20px rgba(15,23,42,0.05);\n\n transition:\n transform 0.25s ease,\n box-shadow 0.25s ease;\n}\n\n\/* =========================\n HOVER\n========================= *\/\n\n.ft-google-mini-btn:hover{\n\n transform:translateY(-2px);\n\n box-shadow:\n 0 8px 18px rgba(15,23,42,0.06),\n 0 18px 30px rgba(37,99,235,0.07);\n}\n\n\/* =========================\n GOOGLE ICON\n========================= *\/\n\n.google-icon{\n\n width:42px;\n\n height:42px;\n\n min-width:42px;\n}\n\n\/* =========================\n CONTENT\n========================= *\/\n\n.mini-btn-content{\n display:flex;\n flex-direction:column;\n}\n\n\/* =========================\n TOP TEXT\n========================= *\/\n\n.mini-top{\n\n font-size:11px;\n\n line-height:1.3;\n\n font-weight:700;\n\n color:#64748b;\n\n margin-bottom:2px;\n}\n\n\/* =========================\n MAIN TEXT\n========================= *\/\n\n.mini-main{\n\n font-size:15px;\n\n line-height:1.35;\n\n font-weight:800;\n\n color:#0f172a;\n}\n\n\/* =========================\n FLATTRADE LOGO\n========================= *\/\n\n.flattrade-logo{\n\n position:relative;\n\n display:inline-block;\n\n font-size:15px;\n\n font-weight:800;\n\n letter-spacing:-0.3px;\n\n color:#111827;\n}\n\n.flattrade-logo span{\n color:#2563eb;\n}\n\n.flattrade-logo small{\n\n position:absolute;\n\n right:-1px;\n\n bottom:-5px;\n\n font-size:4px;\n\n font-weight:800;\n\n color:#2563eb;\n\n letter-spacing:0.4px;\n}\n\n\/* =========================\n GOOGLE COLORS\n========================= *\/\n\n.google-text{\n font-weight:800;\n}\n\n.g-blue{\n color:#4285F4;\n}\n\n.g-red{\n color:#EA4335;\n}\n\n.g-yellow{\n color:#FBBC05;\n}\n\n.g-green{\n color:#34A853;\n}\n\n\/* =========================\n ARROW\n========================= *\/\n\n.arrow{\n color:#2563eb;\n}\n\n\/* =========================\n DESCRIPTION\n========================= *\/\n\n.mini-desc{\n\n margin-top:4px;\n\n font-size:10px;\n\n line-height:1.5;\n\n font-weight:500;\n\n color:#64748b;\n}\n\n\/* =========================\n MOBILE\n========================= *\/\n\n@media(max-width:480px){\n\n .ft-google-mini-btn{\n\n max-width:100%;\n\n padding:12px 14px;\n\n border-radius:16px;\n }\n\n .google-icon{\n\n width:36px;\n\n height:36px;\n\n min-width:36px;\n }\n\n .mini-main,\n .flattrade-logo{\n font-size:13px;\n }\n\n .mini-desc{\n font-size:9px;\n }\n\n}\n\n.ft-google-mini-btn {\n position: relative;\n display: inline-flex;\n align-items: center;\n gap: 14px;\n width: 100%;\n max-width: 420px;\n padding: 14px 16px;\n border-radius: 18px;\n text-decoration: none;\n overflow: hidden;\n font-family: 'Plus Jakarta Sans', sans-serif;\n\n \/* --- ENHANCED BORDER --- *\/\n border: 2px solid #2563eb; \/* Using the brand blue for a strong identity *\/\n \/* Alternative: border: 1.5px solid #cbd5e1; for a subtle slate grey *\/\n \n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 50%, #f4f8fd 100%);\n box-shadow: 0 3px 8px rgba(15,23,42,0.03), 0 10px 20px rgba(15,23,42,0.05);\n transition: all 0.25s ease;\n}\n\n\/* =========================\n HOVER STATE BORDER\n========================= *\/\n.ft-google-mini-btn:hover {\n transform: translateY(-2px);\n border-color: #c5d4ff; \/* Darkens the border slightly on hover *\/\n box-shadow: 0 8px 12px rgba(37,99,235,0.15);\n}\n\n\n\n<\/style>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Molbio Diagnostics IPO \u2013 Flattrade Kosh IPO at a Glance Price Band \u20b9768 to \u20b9807 Face Value \u20b91…","protected":false},"author":10,"featured_media":52774,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"csco_post_video_bg_volume":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-52769","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ipos","cs-entry","cs-video-wrap"],"yoast_head":"\n<title>Molbio Diagnostics IPO - Flattrade Kosh<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molbio Diagnostics IPO - Flattrade Kosh\" \/>\n<meta property=\"og:description\" content=\"Molbio Diagnostics IPO \u2013 Flattrade Kosh IPO at a Glance Price Band \u20b9768 to \u20b9807 Face Value \u20b91…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"Flattrade Kosh\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-07T12:55:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1480\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Prashant Gorhe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@GorhePrashant\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prashant Gorhe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\"},\"author\":{\"name\":\"Prashant Gorhe\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"headline\":\"Molbio Diagnostics IPO\",\"datePublished\":\"2026-08-07T12:55:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\"},\"wordCount\":733,\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"articleSection\":[\"IPOs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\",\"url\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\",\"name\":\"Molbio Diagnostics IPO - Flattrade Kosh\",\"isPartOf\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"datePublished\":\"2026-08-07T12:55:00+00:00\",\"author\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\"},\"breadcrumb\":{\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage\",\"url\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"contentUrl\":\"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg\",\"width\":1480,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/flattrade.in\/kosh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molbio Diagnostics IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#website\",\"url\":\"https:\/\/flattrade.in\/kosh\/\",\"name\":\"Flattrade Kosh\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/flattrade.in\/kosh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2\",\"name\":\"Prashant Gorhe\",\"sameAs\":[\"http:\/\/prashantgorhe.com\",\"https:\/\/www.instagram.com\/prashant_gorhe\/\",\"https:\/\/www.linkedin.com\/in\/prashantgorhe\/\",\"https:\/\/x.com\/GorhePrashant\"],\"url\":\"https:\/\/flattrade.in\/kosh\/author\/prashant\/\"}]}<\/script>\n","yoast_head_json":{"title":"Molbio Diagnostics IPO - Flattrade Kosh","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Molbio Diagnostics IPO - Flattrade Kosh","og_description":"Molbio Diagnostics IPO \u2013 Flattrade Kosh IPO at a Glance Price Band \u20b9768 to \u20b9807 Face Value \u20b91…","og_url":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","og_site_name":"Flattrade Kosh","article_published_time":"2026-08-07T12:55:00+00:00","og_image":[{"width":1480,"height":1000,"url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","type":"image\/jpeg"}],"author":"Prashant Gorhe","twitter_card":"summary_large_image","twitter_creator":"@GorhePrashant","twitter_misc":{"Written by":"Prashant Gorhe","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#article","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/"},"author":{"name":"Prashant Gorhe","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"headline":"Molbio Diagnostics IPO","datePublished":"2026-08-07T12:55:00+00:00","mainEntityOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/"},"wordCount":733,"image":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","articleSection":["IPOs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","url":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/","name":"Molbio Diagnostics IPO - Flattrade Kosh","isPartOf":{"@id":"https:\/\/flattrade.in\/kosh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage"},"image":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","datePublished":"2026-08-07T12:55:00+00:00","author":{"@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2"},"breadcrumb":{"@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#primaryimage","url":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","contentUrl":"https:\/\/flattrade.in\/kosh\/wp-content\/uploads\/2026\/08\/WhatsApp-Image-2026-08-06-at-3.38.48-PM.jpeg","width":1480,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/flattrade.in\/kosh\/molbio-diagnostics-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flattrade.in\/kosh\/"},{"@type":"ListItem","position":2,"name":"Molbio Diagnostics IPO"}]},{"@type":"WebSite","@id":"https:\/\/flattrade.in\/kosh\/#website","url":"https:\/\/flattrade.in\/kosh\/","name":"Flattrade Kosh","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flattrade.in\/kosh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/flattrade.in\/kosh\/#\/schema\/person\/4abc93838bc7642e3e445b74cd627dc2","name":"Prashant Gorhe","sameAs":["http:\/\/prashantgorhe.com","https:\/\/www.instagram.com\/prashant_gorhe\/","https:\/\/www.linkedin.com\/in\/prashantgorhe\/","https:\/\/x.com\/GorhePrashant"],"url":"https:\/\/flattrade.in\/kosh\/author\/prashant\/"}]}},"_links":{"self":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/comments?post=52769"}],"version-history":[{"count":0,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/posts\/52769\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media\/52774"}],"wp:attachment":[{"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/media?parent=52769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/categories?post=52769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flattrade.in\/kosh\/wp-json\/wp\/v2\/tags?post=52769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}